These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16782622

  • 1. Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.
    Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O'Morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G, Limonard C, Hoie O, Vatn M, Moum B, Stockbrügger RW, European Collaborative Study Group On Inflammatory Bowel Disease.
    Scand J Gastroenterol Suppl; 2006; (243):46-54. PubMed ID: 16782622
    [Abstract] [Full Text] [Related]

  • 2. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J.
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [Abstract] [Full Text] [Related]

  • 3. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, Van Deursen C, Hameeteman WH, Wolters FL, Russel MG, Stockbrügger RW.
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [Abstract] [Full Text] [Related]

  • 4. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Hungarian IBD Study Group, Lakatos PL.
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [Abstract] [Full Text] [Related]

  • 5. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B, Ibsen Study Group.
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [Abstract] [Full Text] [Related]

  • 6. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
    Brant SR, Wang MH, Rawsthorne P, Sargent M, Datta LW, Nouvet F, Shugart YY, Bernstein CN.
    Am J Gastroenterol; 2007 Feb; 102(2):313-23. PubMed ID: 17100976
    [Abstract] [Full Text] [Related]

  • 7. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease.
    Jess T, Riis L, Jespersgaard C, Hougs L, Andersen PS, Orholm MK, Binder V, Munkholm P.
    Am J Gastroenterol; 2005 Nov; 100(11):2486-92. PubMed ID: 16279904
    [Abstract] [Full Text] [Related]

  • 8. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
    Seiderer J, Schnitzler F, Brand S, Staudinger T, Pfennig S, Herrmann K, Hofbauer K, Dambacher J, Tillack C, Sackmann M, Göke B, Lohse P, Ochsenkühn T.
    Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
    [Abstract] [Full Text] [Related]

  • 9. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
    Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A.
    Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
    [Abstract] [Full Text] [Related]

  • 10. Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis.
    Odes S, Vardi H, Friger M, Esser D, Wolters F, Moum B, Waters H, Elkjaer M, Bernklev T, Tsianos E, O'Morain C, Stockbrügger R, Munkholm P, Langholz E.
    Aliment Pharmacol Ther; 2010 Apr; 31(7):735-44. PubMed ID: 20047578
    [Abstract] [Full Text] [Related]

  • 11. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Nørregaard P, Moesgaard F, Bendtsen F, Munkholm P, DCCD study group.
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [Abstract] [Full Text] [Related]

  • 12. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [Abstract] [Full Text] [Related]

  • 13. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
    Glas J, Török HP, Tonenchi L, Wetzke M, Beynon V, Teshome MY, Cotofana S, Schiemann U, Griga T, Klein W, Epplen JT, Folwaczny C, Folwaczny M, Mussack T, Weiss EH.
    Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
    [Abstract] [Full Text] [Related]

  • 14. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW.
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [Abstract] [Full Text] [Related]

  • 15. DLG5 variants in inflammatory bowel disease.
    Büning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, Luck W, Buhner S, Molnar T, Nagy F, Lonovics J, Dignass A, Landt O, Nickel R, Genschel J, Lochs H, Schmidt HH, Witt H.
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [Abstract] [Full Text] [Related]

  • 16. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, Kleibeuker JH, Dijkstra G.
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [Abstract] [Full Text] [Related]

  • 17. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C, Schmidt HH, Molnar T, De Jong DJ, Fiedler T, Bühner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Büttner J, Lochs H, Witt H.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):1025-33. PubMed ID: 17877509
    [Abstract] [Full Text] [Related]

  • 18. Contribution of IBD5 locus to clinical features of IBD patients.
    Latiano A, Palmieri O, Valvano RM, D'Incà R, Vecchi M, Ferraris A, Sturniolo GC, Spina L, Lombardi G, Dallapiccola B, Andriulli A, Devoto M, Annese V.
    Am J Gastroenterol; 2006 Feb 01; 101(2):318-25. PubMed ID: 16454837
    [Abstract] [Full Text] [Related]

  • 19. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, Tenchini ML, Porro GB.
    Eur J Gastroenterol Hepatol; 2007 Mar 01; 19(3):217-23. PubMed ID: 17301648
    [Abstract] [Full Text] [Related]

  • 20. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study.
    Sincić BM, Vucelić B, Persić M, Brncić N, Erzen DJ, Radaković B, Mićović V, Stimac D.
    Scand J Gastroenterol; 2006 Apr 01; 41(4):437-44. PubMed ID: 16635912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.